Search

Your search keyword '"immunomodulatory therapy"' showing total 889 results

Search Constraints

Start Over You searched for: Descriptor "immunomodulatory therapy" Remove constraint Descriptor: "immunomodulatory therapy"
889 results on '"immunomodulatory therapy"'

Search Results

2. Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies.

Catalog

Books, media, physical & digital resources

3. Risk of Intestinal Complications, Extraintestinal Morbidity, and Mortality in Patients with Crohn's Disease and Ocular Involvement.

4. Autoimmune Retinopathy Following COVID-19: A Case Report.

5. T cells and macrophages jointly modulate osteogenesis of mesenchymal stromal cells.

6. Lupus nephritis napjainkban.

7. Barriers to Adherence with Immunosuppressive Therapy in Patients with Uveitis.

8. Long-Term Outcomes of Pediatric Pars Planitis: Retrospective Cohort from a Single Tertiary Center in Turkey.

9. Immunohistochemical Expression of Immune Regulatory Proteins in Interface Dermatoses.

10. Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: A cluster analysis.

11. The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis.

12. Dramatic Improvement of Acute Fulminant Lymphocytic Myocarditis with Short-course Intravenous Pulse Corticosteroids: A Case Study

13. The interactions of macrophages, lymphocytes, and mesenchymal stem cells during bone regeneration

14. Risk Factors for Cardiac Involvement in Children with Severe Acute Respiratory Syndrome Coronavirus 2-related Multisystem Inflammatory Syndrome in Children: A Prospective Observational Study

15. Synthetic thymic hexapeptide in the correction of alterations of antibacterial immune defense and normalization of the profile of proinflammatory cytokines in immunocompromized Children with local unlimited acute peritonitis

16. Intestinal pseudo-obstruction in a myasthenia gravis patient after thymectomy: A case report and literature review.

17. Subcutaneous Histaglobulin as an Emerging Therapy in Refractory Chronic Urticaria: A Clinical Evaluation.

18. Das deutsche COVID-19-Rheumaregister.

19. Natalizumab in Multiple Sclerosis: A Single Centre Real-World Study.

20. Protein-based biomarkers in pulmonary malignancies.

21. Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies

22. Network meta-analysis of four common immunomodulatory therapies for the treatment of patients with thin endometrium

23. Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial.

24. INNOVATIONS IN THE TREATMENT OF PEDIATRIC CONJUNCTIVITIS: MODERN SOLUTIONS FOR SMALL PATIENTS

26. Efficacy and Safety of PEGylated Interferons for Relapsing-Remitting Multiple Sclerosis in Adult Patients: Results of Matching-Adjusted Indirect Comparison

27. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis.

28. Spatial transcriptomic brain imaging reveals the effects of immunomodulation therapy on specific regional brain cells in a mouse dementia model.

29. Dramatic Improvement of Acute Fulminant Lymphocytic Myocarditis with Short-course Intravenous Pulse Corticosteroids: A Case Study.

30. Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose.

31. INNOVATIONS IN THE TREATMENT OF PEDIATRIC CONJUNCTIVITIS: MODERN SOLUTIONS FOR SMALL PATIENTS.

32. Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy

33. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies

34. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report

36. Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report.

37. A Rare Presentation: Bilateral Necrotizing Scleritis in Primary Sjögren’s Syndrome.

39. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab

40. Epidemiology and Clinical Course of Pediatric Uveitis in a Tertiary Referral Center in Northeastern Iran.

41. Hantavirus Pulmonary Syndrome Caused by Puumala Orthohantavirus—A Case Report and Literature Review.

42. Diferenciální diagnostika a možnosti léčby recidivujících infekcí dolních dýchacích cest.

43. Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies.

44. B Cell Depletion Therapy as a Cutting-Edge Treatment of Demyelinating Diseases of the Central Nervous System

45. Dynamics of cellular immunity indicators in the complex treatment of acute optic neuritis

46. Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial

47. Hyperinflammatory Syndrome in Patients with COVID-19

48. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis

49. Juvenile idiopathic arthritis and its associated uveitis.

50. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.